| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |